[go: up one dir, main page]

DE60122750D1 - Amidine-inhibitoren der serine-proteasen - Google Patents

Amidine-inhibitoren der serine-proteasen

Info

Publication number
DE60122750D1
DE60122750D1 DE60122750T DE60122750T DE60122750D1 DE 60122750 D1 DE60122750 D1 DE 60122750D1 DE 60122750 T DE60122750 T DE 60122750T DE 60122750 T DE60122750 T DE 60122750T DE 60122750 D1 DE60122750 D1 DE 60122750D1
Authority
DE
Germany
Prior art keywords
serine proteases
inhibitors
factor
amidine
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60122750T
Other languages
English (en)
Other versions
DE60122750T2 (de
Inventor
M Pastor
R Artis
G Olivera
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DE60122750D1 publication Critical patent/DE60122750D1/de
Publication of DE60122750T2 publication Critical patent/DE60122750T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Treating Waste Gases (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60122750T 2000-09-11 2001-09-05 Amidin-Inhibitoren von Serin-Proteasen Expired - Lifetime DE60122750T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23167900P 2000-09-11 2000-09-11
US231679P 2000-09-11
PCT/US2001/027640 WO2002022575A1 (en) 2000-09-11 2001-09-05 Amidine inhibitors of serine proteases

Publications (2)

Publication Number Publication Date
DE60122750D1 true DE60122750D1 (de) 2006-10-12
DE60122750T2 DE60122750T2 (de) 2006-12-21

Family

ID=22870229

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60122750T Expired - Lifetime DE60122750T2 (de) 2000-09-11 2001-09-05 Amidin-Inhibitoren von Serin-Proteasen

Country Status (8)

Country Link
US (2) US6410733B1 (de)
EP (1) EP1317429B1 (de)
JP (1) JP2004509104A (de)
AT (1) ATE338030T1 (de)
AU (1) AU2001288819A1 (de)
CA (1) CA2421548C (de)
DE (1) DE60122750T2 (de)
WO (1) WO2002022575A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291514B1 (en) * 1998-02-09 2001-09-18 3-Dimensional Pharmaceuticals, Inc. Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitors
WO2002022575A1 (en) * 2000-09-11 2002-03-21 Genentech, Inc. Amidine inhibitors of serine proteases
AU2002367752A1 (en) 2001-10-03 2003-11-17 Pharmacia Corporation Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
US20030180804A1 (en) * 2001-10-29 2003-09-25 Corvas International, Inc Solid phase synthesis of chemical libraries
ZA200408711B (en) * 2002-05-28 2006-10-25 Dimensional Pharamaceuticals I Novel thiophene amidines, composition thereof, and methods of treating complement-mediated diseases and conditions
US7659305B2 (en) 2002-10-31 2010-02-09 Pfizer Inc. Therapeutic proline derivatives
HUE025683T2 (hu) 2002-12-03 2016-04-28 Pharmacyclics Llc VIIA faktor inhibitor 2-(2-hidroxi-bifenil-3-il)-1H-benzoimidazol-5-karboxamidin-származékok
BRPI0408420A (pt) * 2003-04-03 2006-03-21 Merck Patent Gmbh compostos de carbonila
JP2007500221A (ja) 2003-05-20 2007-01-11 ジェネンテック・インコーポレーテッド 第VIIa因子のベンゾフラン阻害剤
EP1661881B1 (de) * 2003-08-29 2014-12-17 Ono Pharmaceutical Co., Ltd. Zur bindung an den s1p-rezeptor fähige verbindung und deren pharmazeutische verwendung
US7550487B2 (en) * 2004-03-26 2009-06-23 Hoffmann-La Roche Inc. Pyrrolidine-3,4-dicarboxamide derivatives
PL1637141T3 (pl) * 2004-09-21 2012-04-30 Trobio Ab Stabilizowana kompozycja proteazy zawierająca proteazę serynową, pochodne morfoliny i odwracalne inhibitory tej proteazy serynowej
WO2006073167A1 (ja) * 2005-01-07 2006-07-13 Ono Pharmaceutical Co., Ltd. ピロリジン誘導体
CN102380100A (zh) * 2005-09-22 2012-03-21 特罗比奥股份公司 稳定的蛋白酶组合物
AU2005336535B2 (en) * 2005-09-22 2012-05-24 Trobio Ab Stabilized protease composition
US7601752B2 (en) 2005-11-16 2009-10-13 Hoffmann-La Roche Inc. Pyrrolidine derivatives
US8889117B2 (en) * 2007-02-15 2014-11-18 Yale University Modular nanoparticles for adaptable vaccines
US8236792B2 (en) * 2008-05-23 2012-08-07 Janssen Pharmaceutica Nv Substituted pyrrolidine amides as modulators of the histamine H3 receptor
EP2520566A1 (de) * 2011-05-06 2012-11-07 Orion Corporation Neue pharmazeutische Verbindungen
ES2703344T3 (es) 2013-07-17 2019-03-08 Exxonmobil Chemical Patents Inc Metalocenos y composiciones catalíticas derivadas de ellos
SG10201802959WA (en) 2013-07-17 2018-05-30 Exxonmobil Chemical Patents Inc Cyclopropyl substituted metallocene catalysts
US9464145B2 (en) 2013-07-17 2016-10-11 Exxonmobil Chemical Patents Inc. Metallocenes and catalyst compositions derived therefrom
CN103396351B (zh) * 2013-08-09 2015-10-21 山东大学 吡咯烷类Bcl-2蛋白小分子抑制剂化合物及其制备、药物组合物与制药用途
CN107573277B (zh) * 2013-12-27 2020-10-16 株式会社Api 5-羟基哌啶-2-甲酸的制造方法
CN109312013A (zh) 2016-05-27 2019-02-05 埃克森美孚化学专利公司 茂金属催化剂组合物和使用其的聚合方法
US11472828B2 (en) 2019-10-11 2022-10-18 Exxonmobil Chemical Patents Inc. Indacene based metallocene catalysts useful in the production of propylene polymers
US20230192606A1 (en) * 2020-04-17 2023-06-22 Baylor College Of Medicine Direct thrombin inhibitors and methods of use thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589173A (en) 1986-11-04 1996-12-31 Genentech, Inc. Method and therapeutic compositions for the treatment of myocardial infarction
US5580560A (en) 1989-11-13 1996-12-03 Novo Nordisk A/S Modified factor VII/VIIa
US5374617A (en) 1992-05-13 1994-12-20 Oklahoma Medical Research Foundation Treatment of bleeding with modified tissue factor in combination with FVIIa
US5504064A (en) 1991-04-10 1996-04-02 Oklahoma Medical Research Foundation Treatment of bleeding with modified tissue factor in combination with an activator of FVII
WO1993009804A1 (en) 1991-11-18 1993-05-27 The Scripps Research Institute Serine protease derived-polypeptides and anti-peptide antibodies, systems and therapeutic methods for inhibiting coagulation
JP3194953B2 (ja) 1992-02-14 2001-08-06 コルバス・インターナショナル、インコーポレイテッド 血栓症抑制剤
CA2151044A1 (en) 1992-12-15 1994-06-23 Terence K. Brunck Novel inhibitors for factor xa
US5656600A (en) 1993-03-25 1997-08-12 Corvas International, Inc. α-ketoamide derivatives as inhibitors of thrombosis
US5726159A (en) 1994-03-04 1998-03-10 Eli Lilly And Company Antithrombotic agents
US5681844A (en) 1994-04-18 1997-10-28 Corvas International, Inc. Methionine sulfone and s-substituted cysteine sulfone derivatives as enzyme inhibitors
IL115420A0 (en) 1994-09-26 1995-12-31 Zeneca Ltd Aminoheterocyclic derivatives
US5998379A (en) * 1994-11-21 1999-12-07 Cortech Inc. Serine protease inhibitors-proline analogs
ATE233240T1 (de) 1994-12-02 2003-03-15 Yamanouchi Pharma Co Ltd Neues amidinonaphthylderivat oder dessen salz
US5658930A (en) 1994-12-13 1997-08-19 Corvas International, Inc. Aromatic heterocyclic derivatives as enzyme inhibitors
US5656645A (en) 1994-12-13 1997-08-12 Corvas International, Inc. Aromatic heterocyclic derivatives as enzyme inhibitors
US5612353A (en) 1995-06-07 1997-03-18 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds
WO1997030073A1 (en) 1996-02-13 1997-08-21 Akzo Nobel N.V. Serine protease inhibitors
US6057342A (en) * 1996-08-16 2000-05-02 Dupont Pharmaceutical Co. Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof
US6291514B1 (en) * 1998-02-09 2001-09-18 3-Dimensional Pharmaceuticals, Inc. Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitors
EP1086946A4 (de) * 1998-06-08 2003-03-05 Ajinomoto Kk Benzamidinderivate
WO2002022575A1 (en) * 2000-09-11 2002-03-21 Genentech, Inc. Amidine inhibitors of serine proteases

Also Published As

Publication number Publication date
EP1317429A1 (de) 2003-06-11
US20030229133A1 (en) 2003-12-11
WO2002022575A1 (en) 2002-03-21
ATE338030T1 (de) 2006-09-15
JP2004509104A (ja) 2004-03-25
US6838479B2 (en) 2005-01-04
AU2001288819A1 (en) 2002-03-26
EP1317429B1 (de) 2006-08-30
CA2421548A1 (en) 2002-03-21
CA2421548C (en) 2007-10-30
DE60122750T2 (de) 2006-12-21
US6410733B1 (en) 2002-06-25
US20020055469A1 (en) 2002-05-09

Similar Documents

Publication Publication Date Title
DE60122750D1 (de) Amidine-inhibitoren der serine-proteasen
ATE438615T1 (de) Biarylverbindungen als serinproteaseinhibitoren
DE60023266D1 (de) Serinprotease-inhibitoren
TR200402535T4 (tr) Serin proteaz inhibitörleri.
DK1086122T3 (da) Pyrazinonproteaseinhibitorer
DE60011430D1 (de) Stickstoff enthaltende heterobicyclen als factor xa inhibitoren
NO20091647L (no) Trypsinlignende serinproteaseinhibitorer og deres fremstilling og anvendelse
TR200002904T2 (tr) Amidin bileşikleri
WO1996035788A3 (en) Kunitz type protease inhibitors
TW200745062A (en) Macrocyclic factor VIIA inhibitors useful as anticoagulants
DE69902754D1 (de) Heteroaryl-amidinen,-methylamidinen und -guanidinen als protease inhibitoren, insbesondere als urokinase inhibitoren
ATE275544T1 (de) Serinprotease-inhibitoren
IS5511A (is) Ný efnasambönd
TR199801704T2 (xx) Serin proteaz inhibit�rleri.
DE60113252D1 (de) Inhibitoren von serin proteasen
MXPA01008084A (es) Heteroarilamidinas, metilamidinas y guanidinas como inhibidores de proteasa.
WO1999063090A3 (en) Protease inhibitor peptides
ATE250056T1 (de) Heteroaryl protease inhibitoren und diagnostische bilderzeugungsmittel
WO2002006248A3 (en) Cyclic oxyguanidine pyrazinones as protease inhibitors
ATE407116T1 (de) Neue amidino-derivate und deren verwendung als thrombin-inhibitoren
MXPA03000963A (es) Inhibidores de oxiguanidina ciclica proteasa.
IS7162A (is) Nýjar möndlusýruafleiður og notkun þeirra sem þrombínhemla
TR200102914T2 (tr) Trombin önleyicilerinin önilaçları
PT1075476E (pt) Novos benzimidazoles e benzoxazoles

Legal Events

Date Code Title Description
8364 No opposition during term of opposition